Valeant Pharmaceuticals Intl (VRX)
23.40 -0.83 (-3.43%) 07/13/18 [NYSE]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Fri, Jul 13th, 2018
Results
download Want to compare other data? Select Fields| Symbol | VRX | NBIX | CORT | ||
| Company | Valeant Pharmaceuticals Intl | Neurocrine Bioscienc | Corcept Therapeutics | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 24.15 | 90.45 | 67.35 | ||
| High | 24.43 | 91.28 | 68.87 | ||
| Low | 23.36 | 88.35 | 65.07 | ||
| Last | 23.40 | 90.87 | 68.62 | ||
| Change | -0.83 | +0.15 | +0.89 | ||
| % Change | -3.43% | +0.17% | +1.31% | ||
| Volume | 6,569,300 | 1,620,700 | 1,108,900 | ||
| 20-Day Average Volume | 6,685,200 | 1,518,835 | 2,365,285 | ||
| Previous Close | 24.23 | 90.72 | 67.73 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 23.73 | 105.45 | 68.65 | ||
| 20-Day Raw Stochastic | 18.46% | 20.75% | 23.34% | ||
| 20-Day Relative Strength | 52.09% | 31.35% | 51.14% | ||
| Weighted Alpha | +35.20 | -40.87 | +121.23 | ||
| Today's Opinion | N/A | 100% Sell | 88% Buy | ||
| Previous Opinion | N/A | 100% Sell | 88% Buy | ||
| Last Month's Opinion | N/A | 72% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.92% since 07/06/18 | -5.00% since 04/04/25 | -7.83% since 04/04/25 | ||
| Low | 23.02 on 07/09/18 | 84.23 on 04/09/25 | 64.62 on 04/09/25 | ||
| High | 24.43 on 07/13/18 | 96.43 on 04/07/25 | 77.85 on 04/08/25 | ||
| 1-Month | |||||
| %Chg | -12.88% since 06/13/18 | -15.25% since 03/11/25 | +23.82% since 03/11/25 | ||
| Low | 22.56 on 06/28/18 | 84.23 on 04/09/25 | 53.79 on 03/28/25 | ||
| High | 27.25 on 06/14/18 | 116.23 on 03/26/25 | 117.33 on 03/31/25 | ||
| 3-Month | |||||
| %Chg | +36.44% since 04/13/18 | -35.51% since 01/10/25 | +37.65% since 01/10/25 | ||
| Low | 16.76 on 04/16/18 | 84.23 on 04/09/25 | 49.00 on 01/13/25 | ||
| High | 27.79 on 06/13/18 | 154.61 on 01/30/25 | 117.33 on 03/31/25 | ||
| 6-Month | |||||
| %Chg | -1.85% since 01/12/18 | -21.32% since 10/11/24 | +51.05% since 10/11/24 | ||
| Low | 14.44 on 03/02/18 | 84.23 on 04/09/25 | 42.01 on 10/31/24 | ||
| High | 27.79 on 06/13/18 | 154.61 on 01/30/25 | 117.33 on 03/31/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,159,814 | 9,060,103 | 7,239,616 | ||
| Shares Outstanding, K | 348,710 | 99,704 | 105,503 | ||
| Annual Sales | 8,724,000,000 | 2,355,300,000 | 675,040,000 | ||
| Annual Net Income | 2,404,000,000 | 341,300,000 | 141,210,000 | ||
| Last Quarter Sales | 1,995,000,000 | 627,700,000 | 181,890,000 | ||
| Last Quarter Net Income | -2,693,000,000 | 103,100,000 | 30,750,000 | ||
| 60-Month Beta | -0.38 | 0.33 | 0.15 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.89 on 05/08/18 | 1.00 on 02/06/25 | 0.26 on 02/26/25 | ||
| Latest Earnings Date | 08/14/18 | 05/07/25 | 05/07/25 | ||
| Most Recent Dividend | 1.000 on 11/10/10 | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 6.12 | 27.57 | 54.62 | ||